JACQUELINE CASTAGNO: Open Payments
NPI 1073852885 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,667 in 256 payments from 22 companies in 2025. Trend: 2023 $3,902 · 2024 $4,704 · 2025 $5,667
Food & beverage: $4,767Consulting: $900
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 27 | $1,393 |
| ABBVIE INC. | 37 | $558 |
| Novartis Pharmaceuticals Corporation | 21 | $472 |
| UCB, Inc. | 20 | $463 |
| Janssen Biotech, Inc. | 28 | $397 |
| LEO Pharma Inc. | 9 | $370 |
| PFIZER INC. | 14 | $321 |
| E.R. Squibb & Sons, L.L.C. | 13 | $230 |
| Organon LLC | 20 | $227 |
| GENZYME CORPORATION | 7 | $224 |
Products named: Zoryve, Bimzelx, TREMFYA, COSENTYX, ADBRY, CIBINQO, DUPIXENT, RINVOQ.
Industry payments across MO — which companies pay providers there.
